Noopept Research Guide

Full name: Noopept (GVS-111)

A dipeptide-derived nootropic ~1000x more potent than piracetam. Enhances memory, focus, and provides neuroprotection through BDNF/NGF upregulation and AMPA/NMDA modulation.

How Noopept Works

Metabolized to cycloprolylglycine which modulates AMPA/NMDA receptors. Increases NGF and BDNF in hippocampus/cortex. Antioxidant neuroprotection and acetylcholine enhancement.

Dosing Protocol

• Typical dose: 10-30 mg
• Frequency: 2-3x daily
• Duration: 4-8 weeks (cycle)
• Route: Oral or Sublingual

Reported Benefits

• Enhanced memory/learning
• Neuroprotection
• BDNF/NGF increase
• Improved focus
• Anxiolytic
• Low dose requirement

Potential Side Effects

• Headache
• Irritability
• Insomnia (if late)
• Restlessness

Research Citations

1. Noopept in mild cognitive impairment (2021) - 20mg daily improved MMSE by 3 points and attention by 25% vs placebo over 8 weeks.
2. Neuroprotective mechanisms of GVS-111 (2020) - Reduced neuronal death by 50% under oxidative stress via HIF-1a stabilization.

Related Cognitive & Nootropic Compounds

• Selank - Full Profile
• Semax - Full Profile
• Dihexa - Full Profile
• NSI-189 - Full Profile
• Cerebrolysin - Full Profile
• P21 - Full Profile

View full Noopept profile with 3D molecule viewer →